SCHEMBL8533400

SCHEMBL8533400

Cc1c(-c2ccc(Cc3ccccc3)cc2)[nH]c2ccccc2c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
ATM Q13315 1/20 0.44
CAPN1 P07384 2/20 0.44
CNR1 P21554 1/20 0.43
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8532778 0.90 PTGS2 (0.46) KIF11KDM4EALDH1A1HTTGLA
SCHEMBL8534472 0.88 KDM4E (0.50) SMN1; SMN2KDM4EALDH1A1LMNAHPGD
SCHEMBL8532964 0.84 MAT2A (0.52) KIF11CTSVCTSLNPC1KMT2A
SCHEMBL8533456 0.80 PTGS2 (0.52) KIF11SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL8024152 0.80 CYP2D6 (0.51) SMN1; SMN2HSD17B10KDM4EALDH1A1HTT
SCHEMBL9607489 0.80 HTT (0.48) KIF11SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL26724947 0.78 KIF11 (0.47) KIF11SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL21024209 0.78 PDE10A (0.47) KIF11SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL29045025 0.77 KIF11 (0.62) KIF11SMN1; SMN2HSD17B10KDM4EALDH1A1
SCHEMBL8537794 0.77 MAT2A (0.50) KIF11CTSVCTSLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US claimed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US claimed
WO-2012069856-A1 ANTIMALARIAL COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2012-05-31 WO claimed
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US disclosed
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2020-10-13 US disclosed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US disclosed
US-20190151305-A1 COMBINATION PRODUCT LIVERPOOL SCHOOL TROPICAL MEDICINE (GB) 2019-05-23 US disclosed
WO-2012069856-A1 ANTIMALARIAL COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10799494-B2 Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor NDUFB7, NDUFB3, NDUFB5 KIF11 2588/4885SMN1; SMN2 4817/4885HSD17B10 308/4885
US-20190151305-A1 COMBINATION PRODUCT NDUFB5, NDUFB7, NDUFB10 KIF11 1969/4885SMN1; SMN2 4400/4885HSD17B10 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.